Mingxing Teng

1.5k total citations
24 papers, 661 citations indexed

About

Mingxing Teng is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Mingxing Teng has authored 24 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Mingxing Teng's work include Protein Degradation and Inhibitors (13 papers), Ubiquitin and proteasome pathways (6 papers) and Click Chemistry and Applications (3 papers). Mingxing Teng is often cited by papers focused on Protein Degradation and Inhibitors (13 papers), Ubiquitin and proteasome pathways (6 papers) and Click Chemistry and Applications (3 papers). Mingxing Teng collaborates with scholars based in United States, China and Australia. Mingxing Teng's co-authors include Nathanael S. Gray, Weiwei Zi, Dawei Ma, Tinghu Zhang, John M. Hatcher, Milka Kostić, Nicholas Kwiatkowski, Stephin J. Vervoort, Ricky W. Johnstone and Jennifer R. Devlin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature reviews. Cancer.

In The Last Decade

Mingxing Teng

23 papers receiving 648 citations

Peers

Mingxing Teng
Helen M. Sheldrake United Kingdom
Robert A. Mantei United States
Ted L. Underiner United States
Kurt G. Pike United Kingdom
Christopher Straub United States
Nick Bushby United Kingdom
Sheo S. Singh United States
Tucker R. Huffman United States
Takashi Santou Japan
Mingsong Shi China
Helen M. Sheldrake United Kingdom
Mingxing Teng
Citations per year, relative to Mingxing Teng Mingxing Teng (= 1×) peers Helen M. Sheldrake

Countries citing papers authored by Mingxing Teng

Since Specialization
Citations

This map shows the geographic impact of Mingxing Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxing Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxing Teng more than expected).

Fields of papers citing papers by Mingxing Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxing Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxing Teng. The network helps show where Mingxing Teng may publish in the future.

Co-authorship network of co-authors of Mingxing Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxing Teng. A scholar is included among the top collaborators of Mingxing Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxing Teng. Mingxing Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hassan, Muhammad Murtaza, Yen-Der Li, W Michelle, et al.. (2024). Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues. European Journal of Medicinal Chemistry. 279. 116904–116904. 12 indexed citations
2.
Teng, Mingxing, Jie Jiang, Eric S. Wang, et al.. (2023). Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and Degrader. Angewandte Chemie. 135(18).
3.
Teng, Mingxing & Nathanael S. Gray. (2023). The rise of degrader drugs. Cell chemical biology. 30(8). 864–878. 36 indexed citations
4.
Miao, Qi, et al.. (2023). Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches. Journal of Medicinal Chemistry. 66(19). 13369–13383. 1 indexed citations
5.
Teng, Mingxing, Jie Jiang, Eric S. Wang, et al.. (2023). Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and Degrader. Angewandte Chemie International Edition. 62(18). e202302364–e202302364. 3 indexed citations
6.
Modukuri, Ram K., Zhifeng Yu, Zhi Tan, et al.. (2022). Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections. Proceedings of the National Academy of Sciences. 119(22). e2122506119–e2122506119. 27 indexed citations
7.
Teng, Mingxing, et al.. (2022). The Pursuit of Enzyme Activation: A Snapshot of the Gold Rush. Journal of Medicinal Chemistry. 65(21). 14289–14304. 6 indexed citations
8.
Teng, Mingxing, Marlise R. Luskin, Sandra W. Cowan‐Jacob, et al.. (2022). The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug. Journal of Medicinal Chemistry. 65(11). 7581–7594. 20 indexed citations
9.
Wang, Yong, Zhifeng Yu, Murugesan Palaniappan, et al.. (2022). Advancing ASMS with LC‐MS/MS for the discovery of novel PDCL2 ligands from DNA‐encoded chemical library selections. Andrology. 11(5). 808–815. 3 indexed citations
10.
Teng, Mingxing, Wenchao Lu, Katherine A. Donovan, et al.. (2021). Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216. Journal of Medicinal Chemistry. 65(1). 747–756. 34 indexed citations
11.
Vervoort, Stephin J., Jennifer R. Devlin, Nicholas Kwiatkowski, et al.. (2021). Targeting transcription cycles in cancer. Nature reviews. Cancer. 22(1). 5–24. 95 indexed citations
12.
Teng, Mingxing, et al.. (2020). An Illumination Insensitive Descriptor Combining the CSLBP Features for Street View Images in Augmented Reality: Experimental Studies. ISPRS International Journal of Geo-Information. 9(6). 362–362. 3 indexed citations
13.
Teng, Mingxing, Jie Jiang, Zhixiang He, et al.. (2020). Development of CDK2 and CDK5 Dual Degrader TMX‐2172. Angewandte Chemie International Edition. 59(33). 13865–13870. 57 indexed citations
14.
Teng, Mingxing, Scott B. Ficarro, Hojong Yoon, et al.. (2020). Rationally Designed Covalent BCL6 Inhibitor That Targets a Tyrosine Residue in the Homodimer Interface. ACS Medicinal Chemistry Letters. 11(6). 1269–1273. 29 indexed citations
15.
Zhang, Tinghu, John M. Hatcher, Mingxing Teng, Nathanael S. Gray, & Milka Kostić. (2019). Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation. Cell chemical biology. 26(11). 1486–1500. 124 indexed citations
16.
Teng, Mingxing, Zhixiang Li, Jian Qin, et al.. (2017). Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesia. Bioorganic & Medicinal Chemistry Letters. 27(22). 4979–4984. 4 indexed citations
17.
Li, Zhixiang, Mingxing Teng, Jian Qin, et al.. (2017). The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia. Bioorganic & Medicinal Chemistry Letters. 27(10). 2210–2215. 12 indexed citations
18.
Teng, Mingxing, Weiwei Zi, & Dawei Ma. (2014). Total Synthesis of the Monoterpenoid Indole Alkaloid (±)‐Aspidophylline A. Angewandte Chemie International Edition. 53(7). 1814–1817. 115 indexed citations
19.
Teng, Mingxing, Weiwei Zi, & Dawei Ma. (2014). ChemInform Abstract: Total Synthesis of the Monoterpenoid Indole Alkaloid (.+‐.)‐Aspidophylline A.. ChemInform. 45(32). 1 indexed citations
20.
Teng, Mingxing, Weiwei Zi, & Dawei Ma. (2014). Total Synthesis of the Monoterpenoid Indole Alkaloid (±)‐Aspidophylline A. Angewandte Chemie. 126(7). 1845–1848. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen M. Sheldrake Breakdown of academic impact, for papers by Robert A. Mantei Breakdown of academic impact, for papers by Ted L. Underiner Breakdown of academic impact, for papers by Kurt G. Pike Breakdown of academic impact, for papers by Christopher Straub Breakdown of academic impact, for papers by Nick Bushby Breakdown of academic impact, for papers by Sheo S. Singh Breakdown of academic impact, for papers by Tucker R. Huffman Breakdown of academic impact, for papers by Takashi Santou Breakdown of academic impact, for papers by Mingsong Shi
Rankless by CCL
2026